Surprisingly, however, analysis of JAM-A immunohistochemical staining in a 174-case GE tumor TMA did not reveal any significant correlations between JAM-A protein expression and clinicopathological features such as tumor grade, proliferation, Lauren classification, differentiation, TNM-staging or HER2-positivity. The gene discussed is F11R; the disease is neoplasm.